This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Myriam N Bouchlaka: Innovating in the Field of Stem Cell Research
Introduction
Myriam N Bouchlaka is an accomplished inventor based in Madison, WI, who has made significant contributions to the field of medicine through innovative research. With a focus on harnessing the potential of mesenchymal stem cells, her work addresses critical medical challenges such as graft-versus-host disease (GVHD) and radiation-induced injuries.
Latest Patents
Bouchlaka holds a patent for her groundbreaking invention titled "Use of mesenchymal stem cell-educated macrophages to treat and prevent graft versus host disease and radiation-induced injury." This patent outlines methods for treating and preventing GVHD and tissue damage resulting from radiation exposure. It specifically emphasizes the administration of mesenchymal stem cell-educated macrophages (MEMs) to effectively mitigate these serious health conditions.
Career Highlights
Myriam N Bouchlaka is affiliated with the Wisconsin Alumni Research Foundation, a prestigious organization that focuses on translating academic research into impactful innovations. Her dedication to advancing medical science is exemplified in her singular patent, which positions her as a leader in developing new therapeutic approaches.
Collaborations
Throughout her career, Bouchlaka has collaborated with esteemed colleagues in the field, including Peiman Hematti and Christian M Capitini. These partnerships foster a rich environment for innovation and research, paving the way for potential breakthroughs in regenerative medicine and cellular therapies.
Conclusion
In conclusion, Myriam N Bouchlaka's work stands as a testament to the transformative power of innovation in medicine. Her patented methods for utilizing mesenchymal stem cells hold promise for improving treatment outcomes for patients facing graft-versus-host disease and radiation-induced injuries. As she continues her research, the medical community eagerly anticipates the advancements that will emerge from her invaluable contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile